Clinical trial
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two…
NCT00335270 · Duke University, Other · Completed
Key facts
| NCT number | NCT00335270 |
|---|---|
| Title | A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination |
| Official title | A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination |
| Lead sponsor | Duke University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | fos-amprenavir calcium, ritonavir, abacavir/lamivudine as Epzicom |
| Enrollment | 100 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 9, 2006 |
| Last update posted | May 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: